Viatris Inc. Class Action Lawsuit - VTRS

The filed complaint alleges that Viatris Inc. made materially false and/or misleading statements and/or failed to disclose that: i) the Company was experiencing significantly more competition in its United States complex generics business than disclosed; (ii) the Company was not able to effectively manage its base business erosion or create a stable revenue base; (iii) despite being on the Company’s only growth drivers, Viatris was actively planning to divest its biosimilars business in order to secure enough cash to let it purportedly meet its phase one goals; (iv) Viatris was deviating from the business model it touted throughout the Class Period and undertaking a significant global reshaping of its business which would undermine its ability to achieve stable revenue growth; and (v) the Company was anticipating less financial growth moving into 2022.

In order to be eligible to join the VTRS class action lawsuit, you must have incurred a loss on shares of Viatris purchased during the class period listed above.

If you suffered a loss in Viatris during the relevant time frame or pursuant to the relevant offering(s), you have until July 14, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.